The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental There’s a new way for doctors to treat the ...

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

A legacy bipartisan initiative to combat HIV and AIDS in Africa is collateral damage from President Donald Trump’s directive to halt all U.S. foreign assistance, despite efforts to exempt ...

Exxon Mobil posted strong fourth quarter profits as the oil and gas company increased production in the Permian basin at home ...

The Food and Drug Administration on Tuesday approved Journavx, the first drug in a new class of non-opioid pain medications, ...

Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...